YGION Biomedical, an Austrian biotechnology firm, is dedicated to transforming personalized cancer immunotherapy into reality. By harnessing advanced technologies, it aims to develop tailored treatments that empower patients in their battle against cancer, offering hope and improved outcomes through innovative therapeutic solutions.
National Ranking111th
in Philippines Regional Ranking1909th
in South East Asia Global Ranking52299th
worldwide Rankings by